In January 2019, the OVCRGE discontinued charging fees for IRB review, but continues to charge an institutional review fee for industry-sponsored studies. IRB review of all industry-sponsored studies is ceded to external IRBs and these fees are included in clinical trials agreements and therefore paid by the industry sponsors. To align with our peer institutions and help cover the increased costs of these reviews, this fee will increase from $2,000 to $3,000 on March 1, 2022.